A nanomechanical biosensor based on microcantilevers was implemented to test low molecular weight (small) compounds for their ability to stabilize beta2-microglobulin (beta2-m) in its native conformation. Beta2-m was immobilized on the top face of silicon microcantilevers and it was demonstrated that pH induced unfolding of the immobilized beta2-m drives a specific microcantilever bending. This beta2-m microcantilever assay was then implemented to probe the effect of a pilot set small ligands on beta2-m conformational stability. Among the tested ligands, congo red was the only one able to protect beta2-m from unfolding, that is known to be the primary trigger of its self-polymerization into fibrils and in turn of the onset of amyloidosis. These findings disclose the high potentiality of nanomechanical sensors in the field of protein conformation related diseases, as they bring the unique advantage of directly screening compounds for their specific pharmacological activity rather than for generic binding preferences, effectively shortcutting the identification of the active ones.

Leveraging on nanomechanical sensors to single out active small ligands for beta2-microglobulin

DE LORENZI, ERSILIA;COLOMBO, RAFFAELLA;
2013-01-01

Abstract

A nanomechanical biosensor based on microcantilevers was implemented to test low molecular weight (small) compounds for their ability to stabilize beta2-microglobulin (beta2-m) in its native conformation. Beta2-m was immobilized on the top face of silicon microcantilevers and it was demonstrated that pH induced unfolding of the immobilized beta2-m drives a specific microcantilever bending. This beta2-m microcantilever assay was then implemented to probe the effect of a pilot set small ligands on beta2-m conformational stability. Among the tested ligands, congo red was the only one able to protect beta2-m from unfolding, that is known to be the primary trigger of its self-polymerization into fibrils and in turn of the onset of amyloidosis. These findings disclose the high potentiality of nanomechanical sensors in the field of protein conformation related diseases, as they bring the unique advantage of directly screening compounds for their specific pharmacological activity rather than for generic binding preferences, effectively shortcutting the identification of the active ones.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/624613
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact